Piperazine phenothiazine derivatives for treating spasticity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9814727
SERIAL NO

15124510

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to piperazine phenothiazine derivatives useful as therapeutic agents for treating spasticity, particularly following an ischemia or traumatic injury, or compression syndrome. The invention further relates to a pharmaceutical composition comprising a compound of the invention for treating spasticity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEPARIS FRA
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE D'AIX-MARSEILLEMARSEILLE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boulenguez, Pascale Marseilles, FR 1 2
Gourmand, Laëtitia Marseilles, FR 1 2
Liabeuf, Sylvie Marseilles, FR 1 2
Viallat-Lieutaud, Annelise Marseilles, FR 1 2
Vinay, Laurent Marseilles, FR 1 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 14, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 14, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00